Insulin-producing cells generated from human embryonic stem cells protect mice from diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ricordi, C. & Strom, T. Nat. Rev. Immunol. 4, 259–268 (2004).
Kroon, E. et al. Nat. Biotechnol. 26, 443–452 (2008).
Kubo, A. et al. Development 131, 1651–1662 (2004).
D'Amour, K.A. et al. Nat. Biotechnol. 23, 1534–1541 (2005).
McLean, A.B. et al. Stem Cells 25, 29–38 (2007).
D'Amour, K.A. et al. Nat. Biotechnol. 24, 1392–1401 (2006).
Yang, H. & Wright, J.R. Jr. Endocrinology 143, 2491–2495 (2002).
Fornoni, A. et al. Diabetologia 51, 298–308 (2008).
Osafune, K. et al. Nat. Biotechnol. 26, 313–315 (2008).
Yazawa, K., Fisher, W.E. & Brunicardi, F.C. World J. Surg. 26, 783–789 (2002).
Schuldiner, M., Itskovitz-Eldor, J. & Benvenisty, N. Stem Cells 21, 257–265 (2003).
Fareed, M.U. & Moolten, F.L. Gene Ther. 9, 955–962 (2002).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
H.E. is a cofounder, shareholder and consultant of the unlisted biotech company Betagenon AB, Sweden.
Rights and permissions
About this article
Cite this article
Ricordi, C., Edlund, H. Toward a renewable source of pancreatic β-cells. Nat Biotechnol 26, 397–398 (2008). https://doi.org/10.1038/nbt0408-397
Issue Date:
DOI: https://doi.org/10.1038/nbt0408-397
This article is cited by
-
Islet Cell Transplantion: Update on Current Clinical Trials
Current Transplantation Reports (2016)
-
Current status of islet cell transplantation
Journal of Hepato-Biliary-Pancreatic Surgery (2009)
-
A role for islet neogenesis in curing diabetes
Diabetologia (2009)